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Nucleic Acid Sensing in Innate Immunity
A common theme in antimicrobial, especially antiviral, immunity is the recognition of nucleic acids. In fact, most pathogens expose some type of nucleic acid or degrada-
tion products thereof at some point during their life cycle (e.g., genomic DNA/RNA or RNA transcripts). To this effect, the host has evolved a number of pattern-recognition 
receptors (PRRs) that sense certain components of nucleic acids. Some of these nucleic acid ligands display features that are non-self to the host. For example, unmodified 
5′-phosphorylated RNAs derived from negative-strand RNA virus genomes activate the cytosolic RNA helicase RIG-I. This signature is usually not present within the host cell 
and, as such, is ideally suited to distinguish self from non-self. On the other hand, certain PRRs sense RNA and DNA molecules of both exogenous and endogenous origin, 
even though certain preferences for microbial nucleic acids can exist (e.g., Toll-like receptors). In this regard, the principle of compartmentalization applies, whereas wrongly 
localized nucleic acids are perceived as non-self.
PRRs sensing their ligands are commonly understood as receptors that initiate a broad set of effector functions, e.g., by engaging signaling cascades that lead to the 
activation of transcription factors thus triggering gene expression. In this regard, it is important to note that the activity of certain antimicrobial restriction factors can also be 
linked to a pattern-sensing function that can overlap with a PRR. Yet in contrast to PRRs, restriction factors are typically not understood as initiators of signaling cascades that 
trigger innate immune responses, even though an indirect crosstalk with PRR signaling has been observed for some of these restriction factors.
This SnapShot (part I) and the SnapShot in the next issue (part II) provide an overview on nucleic acid sensing pathways of the mammalian innate immune system that have 
been identified as initiators of signaling cascades leading to antimicrobial gene expression or the activation of inflammatory caspases. Due to space constraints, only recep-
tors for which direct ligand binding of nucleic acids has been demonstrated are included and only their major downstream signaling components are depicted, whereas nega-
tive regulators or modifying components are not included. In light of the fact that the PRR pathways depicted here suggest a vast redundancy in nucleic acid sensing, it has to 
be noted that these pathways have been compiled from studies in different cell types and species, using different ligands and employing different techniques. PRR pathways, 
for which additional genetic proof is required, are depicted in gray and marked with an asterisk.
Cytoplasmic Sensors Upstream of MAVS and STING
RIG-I-like receptors (RLRs) are cytoplasmic DExD/H-box ATPases that detect viral RNAs in a largely complementary manner. RIG-I mainly senses 5′ triphosphate RNA that 
is fully base-paired at its 5′-phosphorylated end, representing a typical signature of negative-strand RNA viruses. MDA5 on the other hand responds to long double-stranded 
RNA, which is commonly observed in cells infected with positive-strand RNA viruses. Upon ligand encounter, RIG-I and MDA5 are recruited to the mitochondrial signaling 
adaptor protein MAVS via their N-terminal tandem caspase activation and recruitment domain (CARD) motifs. This results in the formation of large, prion-like aggregates that 
constitute signaling platforms for the recruitment and activation of TRAF proteins, which in turn lead to the activation of TAK1, IKK, and TBK1/IKKε complexes resulting in 
MAPK, NF-κB, and IRF3 activation. The exact role of the CARD-less RIG-I/MDA5 homolog LGP2 remains to be determined, yet it appears that LGP2 positively regulates MDA5 
activity, whereas it inhibits RIG-I signal transduction. Next to the RLRs, NOD2 was proposed as an alternative PRR functioning upstream of MAVS. To this end, it was shown 
that NOD2 binds to ssRNA and subsequently engages MAVS to drive antiviral gene expression.
In addition, a number of pathways have been described that indirectly feed into the RLR system by providing ligands: RNA polymerase III converts AT-rich DNA into a 5′ 
triphosphate dsRNA molecule, thus resulting in RIG-I-dependent stimulation. Moreover, it has been reported that dsRNA-recognition by the OAS (oligoadenylate synthase) 
system results in the RNase L-dependent degradation of endogenous RNA molecules, which renders them RIG-I stimulatory.
Cytosolic dsDNA, on the other hand, is sensed by the nucleotidyltransferase cGAS, which upon dsDNA recognition performs an allosteric switch inducing its enzymatic 
activity. cGAS produces a 2′-5′ linked cyclic dinucleotide molecule > Gp(2′-5′)Ap(3′-5′) > , cGAMP(2′-5′) that binds to and activates the ER-resident receptor STING. At the 
same time, cGAMP(2′-5′) can also activate STING in bystander cells by being transferred through gap junctions. Upon activation, STING is shuttled to a perinuclear com-
partment where signal transduction is initiated. Of note, it has also been reported that DDX41, as well as IFI16, sense DNA in the cytoplasm, utilizing STING to initiate signal 
transduction, yet additional genetic proof is required to substantiate these models. While all of the above PRRs have been described as functioning upstream of the activa-
tion of transcription factors, LRRFIP1-dependent signaling functions to enhance transcription. RNA or DNA sensing by LRRFIP1 in the cytoplasm results in the activation of 
β-catenin, which subsequently leads to the enhanced recruitment of p300, a coactivator of the IFN-β enhanceosome.
The DNA Damage-Response Pathways
A number of studies have implicated the activation of innate immune effector mechanisms upon the engagement of DNA damage response pathways. Interestingly, some of 
these pathways also appear to respond to exogenous DNA molecules within the cytoplasm. Recruitment of the DNA-PK complex to synthetic or viral DNA molecules leads to 
the activation of TBK1 and subsequent IRF3/7 phosphorylation, whereas direct activation of IRF1 has also been described. On the other hand, assembly of the MRN complex 
in response to cytoplasmic DNA recruits the signaling adaptor molecule CARD9 and thereby activation of the IKK complex. Moreover, a link toward STING/TBK1 activation 
upon Mre11 binding to dsDNA has also been described.
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